NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 59 filers reported holding NEOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $79,000 | +54.9% | 30,250 | -1.8% | 0.00% | – |
| Q4 2018 | $51,000 | -44.0% | 30,814 | +63.9% | 0.00% | – |
| Q3 2018 | $91,000 | -19.5% | 18,798 | +4.2% | 0.00% | – |
| Q2 2018 | $113,000 | -13.7% | 18,037 | +14.0% | 0.00% | – |
| Q1 2018 | $131,000 | -22.9% | 15,819 | -5.1% | 0.00% | -100.0% |
| Q4 2017 | $170,000 | +44.1% | 16,669 | +29.1% | 0.00% | – |
| Q3 2017 | $118,000 | +35.6% | 12,909 | +8.1% | 0.00% | – |
| Q2 2017 | $87,000 | +40.3% | 11,944 | +38.5% | 0.00% | – |
| Q1 2017 | $62,000 | +34.8% | 8,621 | +9.1% | 0.00% | – |
| Q4 2016 | $46,000 | -99.9% | 7,901 | -0.3% | 0.00% | – |
| Q3 2016 | $52,133,000 | -29.0% | 7,923 | +0.2% | 0.00% | – |
| Q2 2016 | $73,414,000 | +115.9% | 7,911 | +148.1% | 0.00% | – |
| Q1 2016 | $34,000,000 | – | 3,189 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 693,582 | $4,057,000 | 2.30% |
| DAFNA Capital Management LLC | 38,873 | $227,000 | 0.20% |
| FALCON POINT CAPITAL, LLC | 85,588 | $501,000 | 0.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 229,166 | $1,341,000 | 0.06% |
| Cormorant Asset Management, LP | 50,613 | $296,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 14,587 | $85,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 80,000 | $468,000 | 0.01% |
| MILLENNIUM MANAGEMENT LLC | 296,175 | $1,733,000 | 0.00% |
| FRANKLIN RESOURCES INC | 1,315,500 | $7,696,000 | 0.00% |
| COLUMBUS CIRCLE INVESTORS | 42,304 | $247,000 | 0.00% |